RA

University of Ioannina Study Evaluates Safety, Efficacy, and Tolerability of Sarilumab for Moderate to Severe RA

Sep 4, 2019 | Monoclonal Antibody, RA, Rheumatoid Arthritis, Sarilumab

Clinical investigators from Greece’s University of Ioannina Medical School evaluated the safety, efficacy, and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis (RA). The Greek investigators concluded beyond any doubt that sarilumab...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

University of Ioannina Study Evaluates Safety, Efficacy, and Tolerability of Sarilumab for Moderate to Severe RA

Pin It on Pinterest